These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6235255)

  • 1. The metyrapone test in affective disorders and schizophrenia.
    Fava GA; Carson SW; Perini GI; Morphy MA; Molnar G; Jusko WJ
    J Affect Disord; 1984 Jun; 6(3-4):241-7. PubMed ID: 6235255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dexamethasone suppression and metyrapone tests in depression.
    Morphy MA; Fava GA; Perini GI; Molnar G; Zielezny M; Lisansky J
    Psychiatry Res; 1985 Jun; 15(2):153-8. PubMed ID: 3862146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metyrapone test in schizophrenic patients and healthy subjects.
    Morphy MA; Fava GA; Carson SW; Perini GI; Molnar G; Jusko WJ
    Neuropsychobiology; 1985; 14(1):35-8. PubMed ID: 4069347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metyrapone test in depressed males.
    Morphy MA; Fava GA; Perini GI; Molnar G
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(2):187-91. PubMed ID: 4001433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metyrapone test in manic patients and healthy subjects.
    Perini GI; Fava GA; Morphy MA; Carson SW; Molnar G; Jusko WJ
    Pharmacopsychiatry; 1984 May; 17(3):94-7. PubMed ID: 6739539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The metyrapone test in affective disorders and schizophrenia II. Changes upon treatment.
    Perini GI; Fava GA; Morphy MA; Carson SW; Molnar G; Jusko WJ
    J Affect Disord; 1984 Dec; 7(3-4):265-72. PubMed ID: 6151957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dexamethasone suppression test in depressive, non-depressive and schizoaffective psychosis.
    Coccaro EF; Prudic J; Rothpearl A; Nurnberg HG
    J Affect Disord; 1985 Sep; 9(2):107-13. PubMed ID: 2932482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dexamethasone suppression test in patients with postpsychotic depressions.
    Siris SG; Rifkin A; Reardon GT; Doddi SR; Foster P; Strahan A; Morgan V
    Biol Psychiatry; 1984 Sep; 19(9):1351-6. PubMed ID: 6498257
    [No Abstract]   [Full Text] [Related]  

  • 9. The dexamethasone suppression test in panic disorder and major depressive episodes.
    Faludi G; Kaskó M; Perényi A; Arató M; Frecska E
    Biol Psychiatry; 1986 Sep; 21(11):1008-14. PubMed ID: 3741916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association performance and the DST.
    Demeter E; Rihmer Z; Arato M; Frecska E
    Psychiatry Res; 1986 Jul; 18(3):289-90. PubMed ID: 3749388
    [No Abstract]   [Full Text] [Related]  

  • 11. Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression. Implications for pathophysiology of DST nonsuppression.
    Holsboer F; von Bardeleben U; Wiedemann K; Müller OA; Stalla GK
    Biol Psychiatry; 1987 Feb; 22(2):228-34. PubMed ID: 3028512
    [No Abstract]   [Full Text] [Related]  

  • 12. The insulin hypoglycaemia and overnight metyrapone tests in the assessment of the hypothalamic-pituitary-adrenal axis following pituitary surgery.
    Courtney CH; McAllister AS; McCance DR; Hadden DR; Leslie H; Sheridan B; Atkinson AB
    Clin Endocrinol (Oxf); 2000 Sep; 53(3):309-12. PubMed ID: 10971447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma MHPG in depressive disorders and relationship to the dexamethasone suppression test.
    Roy A; Jimerson DC; Pickar D
    Am J Psychiatry; 1986 Jul; 143(7):846-51. PubMed ID: 3717423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial dexamethasone suppression tests in psychiatric illness: Part I. A study in schizophrenia and mania.
    Baumgartner A; Gräf KJ; Kürten I
    Psychiatry Res; 1986 May; 18(1):9-23. PubMed ID: 2874578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexamethasone suppression test and sleep deprivation in endogenous depression.
    Kuhs H
    J Affect Disord; 1985 Sep; 9(2):121-6. PubMed ID: 2932484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased pituitary activation following metyrapone administration in post-traumatic stress disorder.
    Yehuda R; Levengood RA; Schmeidler J; Wilson S; Guo LS; Gerber D
    Psychoneuroendocrinology; 1996 Jan; 21(1):1-16. PubMed ID: 8778898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The overnight single-dose metyrapone test is a simple and reliable index of the hypothalamic-pituitary-adrenal axis.
    Fiad TM; Kirby JM; Cunningham SK; McKenna TJ
    Clin Endocrinol (Oxf); 1994 May; 40(5):603-9. PubMed ID: 8013141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothalamic-pituitary-adrenal axis interaction with prostaglandins.
    Thorén M; Stenfors C; Apéria B; Mathé AA
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(3):319-26. PubMed ID: 2359842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dexamethasone suppression test and unipolar-bipolar classification of depression].
    Ayuso Gutiérrez JL; García-Camba E; Cabranes JA; Almoguera MI
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1985; 13(1):1-4. PubMed ID: 4025025
    [No Abstract]   [Full Text] [Related]  

  • 20. [Dexamethasone suppression test (DST): clinical use in psychiatry].
    Morrissette L; Boucher H
    Union Med Can; 1986 Jan; 115(1):58-63. PubMed ID: 3952894
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.